4//SEC Filing
Paulson John 4
Accession 0001013594-25-000742
CIK 0000885590other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 8:17 PM ET
Size
8.7 KB
Accession
0001013594-25-000742
Insider Transaction Report
Form 4
Paulson John
Director
Transactions
- Purchase
Common Stock, no par value
2025-06-10$5.05/sh+754,134$3,808,377→ 27,193,169 total(indirect: By Managed Funds) - Purchase
Common Stock, no par value
2025-06-11$5.24/sh+1,029,098$5,392,474→ 28,222,267 total(indirect: By Managed Funds) - Purchase
Common Stock, no par value
2025-06-12$5.47/sh+1,005,376$5,499,407→ 29,227,643 total(indirect: By Managed Funds)
Footnotes (1)
- [F1]John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.
Documents
Issuer
Bausch Health Companies Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001394923
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 8:17 PM ET
- Size
- 8.7 KB